Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis

Completed · Phase 4

Conditions studied: DeQuervain Tendinopathy

In brief

The purpose of this study is to determine if corticosteroid injection modifies the natural course of de Quervain tendinopathy compared to a toradol injection.

Key facts

Study ID

NCT02604537

Run by

OrthoCarolina Research Institute, Inc.

People needed

62

Starts

2015-10-15

Expected to finish

2024-10-30

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of DeQuervain tendinopathy
• Understands the local language and is willing and able to follow the requirements of the protocol
• Understands the informed consent and signs the institutional review board/independent ethics committee (IRB/IEC) approved informed consent form

You may not qualify if…

• Patients who have an allergy to lidocaine, celestone, or ketorolac, nonsteroidal anti-inflammatory drugs (NSAIDs), or acetylsalicylic acid (ASA)
• Patients who have an adverse reaction to lidocaine, celestone, or ketorolac (such as severe elevation of blood sugars in diabetics that caused medical complication)
• Patients who have received a prior steroid injection within the past three months
• Patients who have had a prior ipsilateral surgery for DeQuervain Tenosynovitis
• Patients that have a skin lesion at the location of injection (such as trauma, eczema, rash)
• Patients who have a current infection at the location of injection
• Patients who have had iontophoresis within three months
• Patients who are breast feeding, pregnant, or who plan to become pregnant in the next six months

Where it is running

• OrthoCarolina — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.